Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
897
datasets available to search
ShareScore release 0.9.0
Dataset results
897 results for “Therapeutic targets”
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma
GEO Series GSE246708. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Discovery, delineation and therapeutic targeting of a hyper-translation pathway driving cytokine release syndrome [CRISPR_screen]
GEO Series GSE287443. Mus musculus. 2 samples. Type: Other.
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
GEO Series GSE274781. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.
Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma [bulk RNA-seq]
GEO Series GSE223061. Homo sapiens. 31 samples. Type: Expression profiling by high throughput sequencing.
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer [RNA-seq_RBKO vs WT]
GEO Series GSE236498. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Identification of p38 beta as a therapeutic target for the treatment of Sézary Syndrome
GEO Series GSE59179. Homo sapiens. 20 samples. Type: Expression profiling by array.
The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic age [RNA-seq]
GEO Series GSE280699. Mus musculus. 78 samples. Type: Expression profiling by high throughput sequencing.
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
GEO Series GSE276715. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
PROTACs therapeutically target the polyglutamine androgen receptor inspinal and bulbar muscular atrophy models
GEO Series GSE297069. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer and nominates c-Met and TRIM24 as therapeutic targets
GEO Series GSE165407. Homo sapiens. 28 samples. Type: Expression profiling by high throughput sequencing.
TRIM24 as therapeutic target in endocrine treatment resistant breast cancer
GEO Series GSE246796. Homo sapiens. 67 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
The single-cell transcriptomic atlas iPain identifies senescence of nociceptors as a therapeutical target for chronic pain treatment
GEO Series GSE253345. Mus musculus. 9 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Genome-wide flow sorting CRISPRi screen identify PTGES3 as a novel therapeutic target of AR
GEO Series GSE180036. Homo sapiens. 14 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing.
Massively targeted evaluation of therapeutic CRISPR off-targets in cells
GEO Series GSE206347. Homo sapiens. 702 samples. Type: Other.
Screening microRNA-196 targets in 11q23-translocation acute myeloid leukemia reveal mechanisms maintaining leukemia stemness with therapeutic potential [RNA-seq]
GEO Series GSE75842. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
MAT2A as key regulator and therapeutic target in MLL leukemogenesis
GEO Series GSE141839. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Unbiased functional identification and therapeutic targeting of T cell neoantigens in a spontaneous murine squamous cell carcinoma [Bulk-seq]
GEO Series GSE125048. Mus musculus. 1 samples. Type: Expression profiling by high throughput sequencing.
Disclosing potential therapeutic targets associated with Osimertinib resistance in non-small cell lung cancer cell line H1975
GEO Series GSE236654. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
GEO Series GSE270182. Mus musculus; Homo sapiens. 15 samples. Type: Expression profiling by high throughput sequencing.
Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease [Duke]
GEO Series GSE303858. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.